Unlisted biotech firm IDT Biologika has won approval from Germany’s vaccine regulator to become the third German company after BioNTech and CureVac to launch human trials of an experimental coronavirus vaccine in the country.
The trial of the vaccine, which has been developed with the German Centre for Infection Research (DZIF), will be conducted on 30 participants aged between 18 and 55 who will receive two vaccinations at four-week intervals.
A larger Phase II trial, which will include elderly volunteers, is planned for the end of this year if the results of the early-stage study show the vaccine is safe and produces an immune response.
https://www.reuters.com/article/health-coronavirus-germany-vaccine/germany-approves-third-trial-of-covid-19-vaccine-candidate-idUSL8N2GT14MHELP US SPREAD GOOD NEWS!
I run this site in my spare time and thoroughly enjoy giving you all positive news! If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.
ENJOY FEEL GOOD, INSPIRING STORIES AND VIDEOS ?
Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.
